scholarly article | Q13442814 |
P2093 | author name string | Zhihong Xu | |
Lin Guo | |||
Xuechu Zhen | |||
Zhuang Wu | |||
Linlang Li | |||
Long-Tai Zheng | |||
P2860 | cites work | Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids | Q24613275 |
Does neuroinflammation fan the flame in neurodegenerative diseases? | Q27498993 | ||
SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity | Q28295413 | ||
Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action | Q28578951 | ||
Sigma receptor ligand, (+)-pentazocine, suppresses inflammatory responses of retinal microglia | Q33702917 | ||
Pharmacology of signaling induced by dopamine D(1)-like receptor activation | Q34126949 | ||
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys | Q34247503 | ||
SKF83959 is a potent allosteric modulator of sigma-1 receptor | Q34321224 | ||
Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke | Q34428140 | ||
Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. | Q34467962 | ||
Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection | Q34626137 | ||
Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand | Q34655101 | ||
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders | Q34795242 | ||
Role of p38 and p44/42 mitogen-activated protein kinases in microglia | Q34963708 | ||
Microglial and macrophage polarization—new prospects for brain repair | Q35394922 | ||
The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements | Q35856904 | ||
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments | Q35902519 | ||
Neurosteroid biosynthesis in the brain of amphibians | Q35971548 | ||
Dual role of inflammation in CNS disease | Q36840391 | ||
In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine | Q36925899 | ||
Neurotransmitter receptors on microglia. | Q36955350 | ||
D5 dopamine receptors are required for dopaminergic activation of phospholipase C. | Q37199115 | ||
The pharmacology of sigma-1 receptors | Q37445561 | ||
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. | Q38050292 | ||
Microglial phagocytosis of live neurons | Q38197408 | ||
Microglia and inflammation: conspiracy, controversy or control? | Q38227727 | ||
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases | Q38236853 | ||
Antiinflammatory effects of orientin-2"-O-galactopyranoside on lipopolysaccharide-stimulated microglia | Q38969184 | ||
Modulation of Ca2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons | Q42496753 | ||
Sigma receptors suppress multiple aspects of microglial activation | Q43116456 | ||
SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain | Q43614902 | ||
SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals? | Q43862501 | ||
SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain | Q44390567 | ||
D1-like dopamine receptor-mediated function in congenic mutants with D1 vs. D5 receptor "knockout". | Q45134892 | ||
The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959. | Q46429865 | ||
Dopamine and noradrenaline control distinct functions in rodent microglial cells. | Q46467964 | ||
Dehydroepiandrosterone (DHEA) metabolism in the brain: identification by liquid chromatography/mass spectrometry of the delta-4-isomer of DHEA and related steroids formed from androstenedione by mouse BV2 microglia | Q46734673 | ||
1-O-tigloyl-1-O-deacetyl-nimbolinin B inhibits LPS-stimulated inflammatory responses by suppressing NF-κB and JNK activation in microglia cells | Q46867127 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microglia | Q1622829 |
allosteric inhibitor | Q70361704 | ||
P304 | page(s) | 904-914 | |
P577 | publication date | 2015-05-29 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation | |
P478 | volume | 134 |
Q39151414 | Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death |
Q29248190 | Activation of the Sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia |
Q64075641 | Allosteric Modulators of Sigma-1 Receptor: A Review |
Q47731890 | Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation |
Q41532363 | Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense. |
Q91895094 | Network topology dynamics of circulating biomarkers and cognitive performance in older Cytomegalovirus-seropositive or -seronegative men and women |
Q39190524 | Potential Roles of Mitochondria-Associated ER Membranes (MAMs) in Traumatic Brain Injury |
Q44345660 | Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome. |
Q38736252 | Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics |
Q38896662 | Role of σ1 Receptors in Learning and Memory and Alzheimer's Disease-Type Dementia |
Q57191691 | Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases |
Q38743350 | Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection |
Q41647730 | Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects |
Q50973291 | The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases. |
Q92617285 | The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD) |
Q57476258 | The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD |
Search more.